evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease.

Saved in:
Bibliographic Details
Title: evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease.
Authors: Cummings, Jeffrey L.1,2 (AUTHOR) jcummings@cnsinnovations.com, Atri, Alireza3,4,5 (AUTHOR), Feldman, Howard H.6 (AUTHOR), Hansson, Oskar7,8 (AUTHOR), Sano, Mary9 (AUTHOR), Knop, Filip K.10,11,12,13 (AUTHOR), Johannsen, Peter13 (AUTHOR), León, Teresa13 (AUTHOR), Scheltens, Philip14,15 (AUTHOR)
Source: Alzheimer's Research & Therapy. 1/8/2024, Vol. 17 Issue 1, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 182152248
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Cummings%2C+Jeffrey+L%2E%22">Cummings, Jeffrey L.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> jcummings@cnsinnovations.com</i><br /><searchLink fieldCode="AR" term="%22Atri%2C+Alireza%22">Atri, Alireza</searchLink><relatesTo>3,4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Feldman%2C+Howard+H%2E%22">Feldman, Howard H.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hansson%2C+Oskar%22">Hansson, Oskar</searchLink><relatesTo>7,8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sano%2C+Mary%22">Sano, Mary</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Knop%2C+Filip+K%2E%22">Knop, Filip K.</searchLink><relatesTo>10,11,12,13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Johannsen%2C+Peter%22">Johannsen, Peter</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22León%2C+Teresa%22">León, Teresa</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Scheltens%2C+Philip%22">Scheltens, Philip</searchLink><relatesTo>14,15</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Alzheimer's+Research+%26+Therapy%22">Alzheimer's Research & Therapy</searchLink>. 1/8/2024, Vol. 17 Issue 1, p1-12. 12p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=182152248
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13195-024-01666-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 1
    Titles:
      – TitleFull: evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cummings, Jeffrey L.
      – PersonEntity:
          Name:
            NameFull: Atri, Alireza
      – PersonEntity:
          Name:
            NameFull: Feldman, Howard H.
      – PersonEntity:
          Name:
            NameFull: Hansson, Oskar
      – PersonEntity:
          Name:
            NameFull: Sano, Mary
      – PersonEntity:
          Name:
            NameFull: Knop, Filip K.
      – PersonEntity:
          Name:
            NameFull: Johannsen, Peter
      – PersonEntity:
          Name:
            NameFull: León, Teresa
      – PersonEntity:
          Name:
            NameFull: Scheltens, Philip
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 01
              Text: 1/8/2024
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 17589193
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Alzheimer's Research & Therapy
              Type: main
ResultId 1